Skip to main content

Table 2 Cancer cases diagnosed in the study population

From: Availability of anticancer medicines in public and private sectors, and their affordability by low, middle and high-income class patients in Pakistan

Sr. No

Cancer

ICD-10

Male (n = 2436)

Female (n = 1964)

Total (n = 4400)

n (%)

n (%)

n (%)

1

Bladder

C67

42 (1.7)

32 (1.6)

74 (1.7)

2

Brain

C70–72

111 (4.6)

70 (3.6)

181 (4.1)

3

Breast

C50

378 (19.2)

378 (8.6)

4

Cervix uteri

C53

142 (7.2)

142 (3.2)

5

Colorectal

C18–21

131 (5.4)

43 (2.2)

174 (4.0)

6

Corpus uteri

C54

71 (3.6)

71 (1.6)

7

Gallbladder

C23–24

110 (4.5)

71 (3.6)

181 (4.1)

8

Hodgkin lymphoma

C81

149 (6.1)

43 (2.2)

192 (4.4)

9

Kidney

C64–66

178 (7.3)

114 (5.8)

292 (6.6)

10

Larynx

C32

111 (4.6)

70 (3.6)

181 (4.1)

11

Leukemia

C91–95

221 (9.1)

113 (5.8)

334 (7.6)

12

Lip, oral cavity

C00–08

110 (4.5)

70 (3.6)

180 (4.1)

13

Liver

C22

111 (4.6)

70 (3.6)

181 (4.1)

14

Lung

C33–34

186 (7.6)

104 (5.3)

290 (6.6)

15

Non-Hodgkin lymphoma

C82–85

363 (14.9)

177 (9.0)

540 (12.3)

16

Esophagus

C15

107 (4.4)

71 (3.6)

178 (4.0)

17

Ovary

C56

141 (7.2)

141 (3.2)

18

Pancreas

C25

111 (4.6)

70 (3.6)

181 (4.1)

19

Prostate

C61

220 (9.0)

220 (5.0)

20

Stomach

C16

65 (2.7)

43 (2.2)

108 (2.5)

21

Thyroid

C73

110 (4.5)

71 (3.6)

181 (4.1)